Skip Navigation Links
Home
About Us
Therapeutic Focus
Technology
News and Publications
Careers
Contact Us
 
H/D Exchange
 
Skip Navigation Links
ExSAR Signs New Licensing Agreement with Sick Kids Hospital With Focus on Gaucher Disease
ExSAR has signed a licensing agreement with Sick Kids Hospital, University of Toronto, Toronto, Canada for the development of ExSAR-202 for the potential treatment of Gaucher disease.


Press Releases | Presentations & Conferences | Publications | Media Coverage | Links

Epitope Mapping
  Hydrogen/Deuterium Exchange Mass Spectrometry (HDMX)
 
Home   |   About Us   |   Therapeutic Focus   |   Technology   |   News and Publications   |   Careers   |   Contact Us   |   Sitemap
ExSAR is a trademark of ExSAR Corporation. Content © 2008 ExSAR Corporation. Terms of Use © 2008
11 Deer Park Drive, Suite 103   |   Monmouth Junction, New Jersey 08852   |   Phone: (732) 438-6500   |   Fax: (732) 438-1919
Optimized for resolutions of 1024 x 768 or higher with Microsoft Internet Explorer 6.0 or later
Web Site Designed and Maintained by Stonehouse Media Incorporated©